Evidence map›Paper›PMID 37048816›Full record

ArticleJournal of clinical medicine2023

Opioids for Osteoarthritis: Cross-Sectional Survey of Patient Perspectives and Satisfaction.

Thomas J Schnitzer, Rebecca L Robinson, Lars Viktrup, Joseph C Cappelleri, Andrew G Bushmakin, Leslie Tive, Mia Berry, Chloe Walker, James Jackson

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Thomas J SchnitzerFeinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Rebecca L RobinsonValue, Evidence and Outcomes, Eli Lilly and Company, Indianapolis, IN 46285, USA.ORCID 0000-0003-1490-0491
Lars ViktrupNeuroscience, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Joseph C CappelleriStatistical Research and Data Science Center, Pfizer Inc., New York, NY 10017, USA.ORCID 0000-0001-9586-0748
Andrew G BushmakinStatistical Research and Data Science Center, Pfizer Inc., New York, NY 10017, USA.
Leslie TiveInternal Medicine, Global Medical Affairs, Pfizer Inc., New York, NY 10017, USA.ORCID 0000-0002-6386-0839
Mia BerryReal World Research, Adelphi Real World, Bollington SK10 5JB, UK.
Chloe WalkerReal World Research, Adelphi Real World, Bollington SK10 5JB, UK.
James JacksonReal World Research, Adelphi Real World, Bollington SK10 5JB, UK.
Adelphi Group (United Kingdom) · GBPfizer (United States) · USEli Lilly (United States) · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients often take opioids to relieve osteoarthritis (OA) pain despite limited benefits and potential harms. This study aimed to compare cross-sectional perspectives of patients that were taking prescription opioid (N = 471) or nonopioid medications (N = 185) for OA in terms of satisfaction, expectations of effectiveness, and concerns. Patients prescribed opioids (>7 days) reported more prior treatments (2.47 vs. 1.74), greater mean pain intensity (5.47 vs. 4.11), and worse quality of life (EQ-5D-5L index value mean 0.45 vs. 0.71) than patients prescribed nonopioid medications (all

Indexed as

opioidosteoarthritisprescription analgesicreal-world clinical practicetramadol

Identifiers

PMID37048816
PMCPMC10095440
OpenAlexW4362667667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.